T. Rowe Price Associates’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.56M | Sell |
|
|||||
|
2025
Q2 | $4.56M | Sell |
|
|||||
|
2025
Q1 | $6.14M | Sell |
|
|||||
|
2024
Q4 | $9.55M | Sell |
|
|||||
|
2024
Q3 | $13.6M | Sell |
|
|||||
|
2024
Q2 | $13.5M | Buy |
|
|||||
|
2024
Q1 | $18.7M | Buy |
|
|||||
|
2023
Q4 | $7.61M | Sell |
|
|||||
|
2023
Q3 | $7.63M | Sell |
|
|||||
|
2023
Q2 | $26.5M | Sell |
|
|||||
|
2023
Q1 | $31.3M | Buy |
|
|||||
|
2022
Q4 | $37.4M | Buy |
|
|||||
|
2022
Q3 | $63.8M | Buy |
|
|||||
|
2022
Q2 | $63.4M | Buy |
|
|||||
|
2022
Q1 | $38.9M | Buy |
|
|||||
|
2021
Q4 | $48.5M | Sell |
|
|||||
|
2021
Q3 | $112M | Buy |
|
|||||
|
2021
Q2 | $92.2M | Buy |
|
|||||
|
2021
Q1 | $122M | Sell |
|
|||||
|
2020
Q4 | $89.8M | Sell |
|
|||||
|
2020
Q3 | $135M | Sell |
|
|||||
|
2020
Q2 | $162M | Buy |
|
|||||
|
2020
Q1 | $42.9M | Sell |
|
|||||
|
2019
Q4 | $64.2M | Sell |
|
|||||
|
2019
Q3 | $68.6M | Sell |
|
|||||
|
2019
Q2 | $67.7M | Buy |
|
|||||
|
2019
Q1 | $70.9M | Buy |
|
|||||
|
2018
Q4 | $65.9M | Buy |
|